Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

Post Conference Review and Analysis of mCRC Data from ASCO 2021

Program Overview

In this module, Michael Overman, MD, along with Scott Kopetz, MD, PhD, course chair, will highlight information presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting. The faculty will first analyze data regarding frontline metastatic colorectal cancer (mCRC), including the Keynote 177 and FOCUS 4N studies. Following, updates for both second-line mCRC and refractory mCRC ...
View Course
Review of Targeted Therapeutic Options for BRAF-Mutated Metastatic Colorectal Cancer, Including Combination Therapies

Program Overview

In this module, Benny Johnson, DO, along with Scott Kopetz, MD, PhD, course chair, will analyze targeted therapeutic options for BRAF-mutated metastatic colorectal cancer, with a focus on combination therapies. The faculty will highlight the pathway to precision therapy for BRAFV600E mutant metastatic colorectal cancer (mCRC), debating the clinical implications of recent trial data in an interactive panel ...
View Course
Update on Optimal Biomarker and Genomic Testing for Colorectal Cancer, Including BRAF Mutations

Program Overview

In this module, Christopher Lieu, MD, along with Scott Kopetz, MD, PhD, course chair, will first discuss the current landscape of genomic testing for metastatic colorectal cancer (mCRC), highlighting the changes in the last decade. Following, the faculty will analyze testing options, covering topics such as gene sequencing, genomic profiling and liquid biopsy and circulating tumor DNA. To ...
View Course
Novel Treatment Strategies for Sphingosine-1-Phosphate Therapeutics to Manage Patients with Moderate to Severe Ulcerative Colitis

Program Overview

This CME/CE activity will highlight novel treatment strategies for sphingosine-1-phosphate (S1P) therapeutics to manage patients with moderate to severe ulcerative colitis (UC). The expert faculty, led by Dr. David T. Rubin, will first review the need for new therapeutics in ulcerative colitis, including treatment goals and unmet needs. Next, the faculty will analyze the science of S1P receptor ...
View Course
Applying S1P Therapeutics to Improve Outcomes for Patients with Moderate to Severe Ulcerative Colitis

Program Overview

This CME activity is derived from content presented at the Digestive Disease Week (DDW) 2021 Virtual Meeting. The expert faculty will highlight sphingosine-1-phosphate (S1P) therapeutics to improve outcomes for patients with moderate to severe ulcerative colitis (UC). Additionally, a review of S1P receptor modulators as a therapeutic target to support the management of ulcerative colitis will be discussed ...
View Course
Advances in Patient-Controlled On-Demand Treatment of Paroxysmal Supraventricular Tachycardia

Program Overview

Unpredictable episodes of paroxysmal supraventricular tachycardia (PSVT) often have a negative impact on patient quality of life by causing uncomfortable, disconcerting symptoms during episodes (e.g., palpitations, chest pain, dizziness, syncope, shortness of breath, anxiety), by imposing restrictions on patient activities, and by potential association with medication-related side effects. Among commercially insured patients, healthcare spending increases substantially following diagnosis ...
View Course

Upcoming Events

2021 Joint Pre-ECTRIMS Online Workshop

October 11th – 12th, 2021

CME/CE Symposium at the Congress of Clinical Rheumatology West Meeting

September 19th, 2021

2021 Consortium of Multiple Sclerosis Centers Annual Meeting

October 25th – 28th, 2021

Advanced Curriculum for Multiple Sclerosis 2022

February 22nd, 2022